eli lilly glp 1 lawsuit Novo Nordisk on Tuesday filed a against Lilly, alleging that its advertising campaigns for its blockbuster obesity and diabetes drugs are designed to mislead consumers about their superior efficacy relative Novo Sues Lilly; Missing Wegovy

The 2026 Dosing Answer Its the question we hear all the time at TrimrX, from new patients just starting their journey to curious individuals trying to understand the massive shift in weight management we've seen unfold

A lower all-cause dementia risk associated with SGLT2 inhibitors was found among those with atherosclerotic cardiovascular disease (HR [95% CI]: 0.80 [0.680.95]) and renal insufficiency (HR [95% CI]: 0.80 [0.650.99])

This consistent pattern allows your body to respond predictably to appetite suppression, improved insulin sensitivity, and metabolic changes

It may appeal to clinicians and payers as an extension of semaglutide rather than a completely new receptor strategy